ERG anticorps (full length)

N° du produit ABIN7878180

L’anticorps anti-ERG Monoclonal Souris est utilisé pour la détection de ERG dans des échantillons de Humain. Il a été validé pour IHC (p).

Aperçu rapide pour ERG anticorps (full length) (ABIN7878180)

Antigène: ERG (ERG, ETS transcription factor (ERG))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp ERG est non-conjugé

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone: ERG-2107

Détail du produit anti-ERG anticorps

Épitope: full length

Fonction: ERG Antibody / Transcriptional regulator ERG

Purification: Protein A/G affinity

Immunogène: Recombinant human full-length ERG protein was used as the immunogen for the ERG antibody.

Isotype: IgG2b, kappa

Information d'application

Indications d'application: Optimal dilution of the ERG antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.2 mg/mL

Buffer: 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Aliquot the ERG antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Détails sur ERG

Antigène: ERG (ERG, ETS transcription factor (ERG))

Autre désignation: ERG

Sujet: The transcription factor erythroblastosis virus E26 transforming sequence related gene (ERG) functions as a regulator of key cellular functions to promote endothelial homeostasis. Expression of ERG has been observed in both benign and malignant vascular endothelial tumors, such as hemangiomas and Kaposi sarcomas, respectively. Carcinomas of the breast, colon, and urothelium have demonstrated absence of ERG expression, whereas presence of the protein has been confirmed in a subset of prostate carcinoma cases. Anti-ERG can be a useful tool for identifying vascular endothelial neoplasms and distinguishing prostate carcinoma from epithelial tumors of non-prostatic origin.

UniProt: P11308